Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More - Awakn Life Sciences (OTC:AWKNF), ATAI Life Sciences (NASDAQ:ATAI)
President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.
Source: benzinga.com